Cargando…

Psychosis in Parkinson’s Disease: A Lesson from Genetics

Psychosis in Parkinson’s disease (PDP) represents a common and debilitating condition that complicates Parkinson’s disease (PD), mainly in the later stages. The spectrum of psychotic symptoms are heterogeneous, ranging from minor phenomena of mild illusions, passage hallucinations and sense of prese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelopoulou, Efthalia, Bougea, Anastasia, Papageorgiou, Sokratis G., Villa, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222985/ https://www.ncbi.nlm.nih.gov/pubmed/35741861 http://dx.doi.org/10.3390/genes13061099

Ejemplares similares

Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Migraine, Tension-Type Headache and Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Cognitive Impairment in Parkinson’s Disease: An Updated Overview Focusing on Emerging Pharmaceutical Treatment Approaches
por: Degirmenci, Yildiz, et al.
Publicado: (2023)

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

Ambiental Factors in Parkinson’s Disease Progression: A Systematic Review
por: Bougea, Anastasia, et al.
Publicado: (2023)

Arylsulfatase A (ASA) in Parkinson’s Disease: From Pathogenesis to Biomarker Potential
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

The Landscape of Monogenic Parkinson’s Disease in Populations of Non-European Ancestry: A Narrative Review
por: Koros, Christos, et al.
Publicado: (2023)

Prosopagnosia, Other Specific Cognitive Deficits, and Behavioral Symptoms: Comparison between Right Temporal and Behavioral Variant of Frontotemporal Dementia
por: Koros, Christos, et al.
Publicado: (2022)

New‑onset non‑motor symptoms in patients with Parkinson's disease and post‑COVID‑19 syndrome: A prospective cross‑sectional study
por: Bougea, Anastasia, et al.
Publicado: (2023)

Serum Uric Acid as a Putative Biomarker in Prodromal Parkinson’s Disease: Longitudinal Data from the PPMI Study
por: Koros, Christos, et al.
Publicado: (2023)

How Telemedicine Can Improve the Quality of Care for Patients with Alzheimer’s Disease and Related Dementias? A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson’s Disease and Asymptomatic Carriers of Related Genes: A Brief Report
por: Koros, Christos, et al.
Publicado: (2023)

Rhythmic cueing, dance, resistance training, and Parkinson's disease: A systematic review and meta-analysis
por: Karpodini, Claire Chrysanthi, et al.
Publicado: (2022)

Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease
por: Pachi, Ioanna, et al.
Publicado: (2023)

Characteristics and outcomes of elderly patients with Parkinson's disease hospitalized due to COVID‑19‑associated pneumonia
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Can sars-cov-2 infection exacerbate Alzheimer’s disease? A systematic review
por: Chiara, Villa, et al.
Publicado: (2021)

Phenomenology and management of cognitive and behavioral disorders in Parkinson's disease. Rise and logic of dementia in Parkinson's disease
por: Potagas, Constantin, et al.
Publicado: (2006)

Silent Pauses and Speech Indices as Biomarkers for Primary Progressive Aphasia
por: Potagas, Constantin, et al.
Publicado: (2022)

Genetics of Multiple System Atrophy and Progressive Supranuclear Palsy: A Systemized Review of the Literature
por: Bougea, Anastasia
Publicado: (2023)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Parkinson Disease Psychosis: Update
por: Friedman, J. H.
Publicado: (2013)

Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease
por: Pachi, Ioanna, et al.
Publicado: (2023)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2020)

Update on the treatment of Parkinson’s disease psychosis: role of pimavanserin
por: Combs, Brianna L, et al.
Publicado: (2017)

Psychosis in Parkinson's disease
Publicado: (2011)

Psychosis in Parkinson’s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges
por: Waddington, John L.
Publicado: (2020)

Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
por: Paudel, Yam Nath, et al.
Publicado: (2020)

Clock-Drawing Tasks as Predictive Measurements for Disease Classification Among Patients With Parkinson’s Disease and Essential Tremor
por: Bougea, Anastasia M, et al.
Publicado: (2021)

Pimavanserin and Parkinson’s Disease Psychosis: A Narrative Review
por: Rissardo, Jamir Pitton, et al.
Publicado: (2022)

Psychosis in parkinsonism: an unorthodox approach
por: Onofrj, Marco, et al.
Publicado: (2017)

Functional Implications of Protein Arginine Methyltransferases (PRMTs) in Neurodegenerative Diseases
por: Angelopoulou, Efthalia, et al.
Publicado: (2023)

B12 as a Treatment for Peripheral Neuropathic Pain: A Systematic Review
por: Julian, Thomas, et al.
Publicado: (2020)

Current and Future Treatments in Alzheimer Disease: An Update
por: Yiannopoulou, Konstantina G, et al.
Publicado: (2020)

The Effects of a Single Session of a Rhythmic Movement Program on Selected Biopsychological Parameters in PD Patients: A Methodological Approach
por: Karpodini, Claire Chrysanthi, et al.
Publicado: (2023)

MicroRNA as Candidate Biomarkers in Atypical Parkinsonian Syndromes: Systematic Literature Review
por: Bougea, Anastasia
Publicado: (2022)

Predictors of COVID‑19‑associated mortality among hospitalized elderly patients with dementia
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanisms
por: Zhang, Shuo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pfj90tgj82henljp3bn61leak2